文献速递心力衰竭与心肌病冠心病

运动与肥厚型心肌病心肌损伤

Exercise and myocardial injury in hypertrophic cardiomyopathy.
PubMed 文献 · Heart · 2020-01-30

该多中心研究评估肥厚型心肌病(HCM)患者及无肥厚突变携带者运动后肌钙蛋白升高的发生率及决定因素。HCM患者运动后肌钙蛋白升高占18%,突变携带者占4%(p=0.01)。T2加权高信号是肌钙蛋白升高的唯一独立预测因子(调整OR 7.9;95%CI 2.7至23.3;p<0.001)。

要点

  • HCM患者运动后肌钙蛋白升高约20%,显著高于突变携带者。
  • T2加权高信号是运动后肌钙蛋白升高的独立预测因子。
  • 最大心率和最大室壁厚度更高者更易出现运动后肌钙蛋白升高。

核心结论

  • HCM患者运动后肌钙蛋白升高约20%,是无肥厚突变携带者的近5倍。
  • 心脏磁共振T2加权高信号可能识别易损患者,提示活动性疾病状态。

研究设计与样本

  • 多中心项目纳入HCM患者和无肥厚突变携带者(对照)。
  • 参与者进行症状限制性自行车试验,运动前和运动后6小时检测高敏肌钙蛋白T。
  • HCM患者运动前行心脏磁共振评估肥厚和心肌损伤。

主要发现

  • 运动后肌钙蛋白升高在HCM患者中占18%(23/127),突变携带者中占4%(2/53),p=0.01。
  • 有运动后肌钙蛋白升高的HCM患者最大心率更高(157±19 vs 143±23,p=0.004)。
  • 有运动后肌钙蛋白升高的HCM患者最大室壁厚度更大(20 mm vs 17 mm,p=0.023)。
  • 有运动后肌钙蛋白升高的HCM患者晚期钆增强更常见(85% vs 57%,p=0.02)。
  • T2加权高信号在肌钙蛋白升高组占65%(13/20),无升高组占19%(15/79),p<0.001。

关键数值与推荐

  • 基线肌钙蛋白<13 ng/L时,升高定义为>50%增加;>13 ng/L时定义为>20%增加。
  • T2加权高信号是运动后肌钙蛋白升高的唯一独立预测因子(调整OR 7.9;95%CI 2.7至23.3;p<0.001)。

临床怎么用

  • 对HCM患者运动后肌钙蛋白升高应结合基线水平判读。
  • 心脏磁共振T2加权高信号可能帮助识别运动后易发生心肌损伤的HCM患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Troponin and high signal intensity on T2-weighted (HighT2) cardiovascular magnetic resonance imaging (CMRi) are both markers of myocardial injury in hypertrophic cardiomyopathy (HCM). The interplay between exercise and disease development remains uncertain in HCM. We sought to assess the occurrence of postexercise troponin rises and its determinants. METHODS: Multicentre project on patients with HCM and mutation carriers without hypertrophy (controls). Participants performed a symptom limited bicycle test with hs-cTnT assessment pre-exercise and 6 hours postexercise. Pre-exercise CMRi was performed in patients with HCM to assess measures of hypertrophy and myocardial injury. Depending on baseline troponin (< or >13 ng/L), a rise was defined as a >50% or >20% increase, respectively. RESULTS: Troponin rises occurred in 18% (23/127) of patients with HCM and 4% (2/53) in mutation carriers (p=0.01). Comparing patients with HCM with and without a postexercise troponin rise, maximum heart rates (157±19 vs 143±23, p=0.004) and maximal wall thickness (20 mm vs 17 mm, p=0.023) were higher in the former, as was the presence of late gadolinium enhancement (85% vs 57%, p=0.02). HighT2 was seen in 65% (13/20) and 19% (15/79), respectively (p<0.001). HighT2 was the only independent predictor of troponin rise (adjusted odds ratio 7.9; 95% CI 2.7 to 23.3; p<0.001). CONCLUSIONS: Postexercise troponin rises were seen in about 20% of patients with HCM, almost five times more frequent than in mutation carriers. HighT2 on CMRi may identify a group of particularly vulnerable patients, supporting the concept that HighT2 reflects an active disease state, prone to additional injury after a short episode of high oxygen demand.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Cramer GE, Gommans DHF, Dieker HJ, et al. Exercise and myocardial injury in hypertrophic cardiomyopathy. Heart. 2020. PMID: 32001622. doi:10.1136/heartjnl-2019-315818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。